Full Text
Cost-Effectiveness of Pembrolizumab for Unresectable Metastatic Melanoma After Progression with Ipilimumab in England

Abstract

Authors

E Marriott C Praet R Aguiar-Ibáñez J Pellissier R Xu J Wang

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×